Abstract
Glucocorticoids like predniso(lo)ne and dexamethasone are well known for their antileukemic activity, especially in acute lymphoblastic leukemia (ALL). Several groups have investigated the sensitivity of malignant lymphoid cells to glucocorticoids (GCs) and possibilities to predict this sensitivity. Special attention was given to the correlation between GC receptor numbers and sensitivity to these drugs, with conflicting results [1–4]. The clinical response to an initial prednisone (PRD) monotherapy was shown to have prognostic value in childhood ALL, firstly in small patient-groups [3, 5], later in the large BFM-ALL 83 study [6]. Differences in GC sensitivity might be important to consider in the design of an optimal treatment for each individual. In vitro sensitivity testing is an attractive method to investigate these differences.
Supported by the Dutch Cancer Society (IKA 87–17 and IKA 89–06).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lippman ME, Konior G, Leventhal BG (1978) Clinical implications of glucocorticoid receptors in human leukemia. Cancer Res 38: 4251–4256
Homo F, Duval D, Harousseau JL et al. (1980) Heterogeneity of the in vitro responses to glucocorticoids in acute leukemia. Cancer Res 40: 2601–2608
Pui C-H, Dahl GV, Rivera G et al. (1984) The relationship of blast cell glucocorticoid receptor levels to response to single-agent steroid trial and remission response in children with acute lymphoblastic leukemia. Leuk Res 8: 579–585
Nanni P, Nicoletti G, Prodi G et al. (1982) Glucocorticoid receptor and in vitro sensitivity to steroid hormones in human lymphoproliferative diseases and myeloid leukemia. Cancer 49: 623–632
Mastrangelo R, Riccardi R, Corbo S et al. (1984) Prediction of clinical response to glucocorticoids in children with acute lymphoblastic leukemia. Eur Paediatr Haematol Oncol 1: 33–36
Riehm H, Reiter A, Schrappe M et al. (1986) Die Corticosteroidabhängige Dezimierung der Leukämiezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leukämie im Kindesalter (Therapiestudie ALL-BFM 83). Klin Pädiatr 199: 151–160
Lerner LJ, Bianchi A, Turkheimer AR et al. (1964) Anti-inflammatory steroids: potency, duration and modification of activities. Ann N Y Acad Sci 116: 1071–1077
Nakai T (1961) Influences of small doses of various corticosteroids on the incidence of chemically induced subcutaneous sarcomas in mice. Cancer Res 21: 221–227
Jones B, Shuster JJ, Holland J (1984) Lower incidence of meningeal leukemia when dexamethasone is substituted for prednisone in the treatment of acute lymphoblastic leukemia — a late follow-up. Proc Am Soc Clin Oncol 3: 191 (abstract)
Veerman AJP, Hählen K, Kamps WA et al. (1990). Dutch Childhood Leukemia Study Group: early results of study ALL VI. In: Büchner T, Schellong G, Hiddemann W, Ritter J (eds) Acute leukemias II. Springer, Berlin, Heidelberg New York, pp 473–477
Sargent JM, Taylor CG (1989) Appraisal of the MIT assay as a rapid test of chemosensitivity in acute myeloid leukemia. Br J Cancer 60: 206–210
Hongo T, Fujii Y, Igarashi Y (1990) An in vitro chemosensitivity test for the screening of anti-cancer drugs in childhood leukemia. Cancer 65: 1263–1272
Pieters R, Loonen AH, Huismans DR et al. (1990) In vitro drug sensitivity of cells from children with leukemia using the MTTassay with improved culture conditions. Blood 76: 2327–2336
Pieters R, Kaspers GJL, Van Wering ER et al. (1991) In vitro drug resistance in childhood acute lymphoblastic leukemia in relation to age and immunophenotype. This volume
Pieters R, Huismans DR, Loonen AH et al (1991). Relations of cellulas drug resistance to long-term clinical outcome in childhood acute lymphoblastic leukemia. Lancet 338: 399–403
Van Dongen JJM, Adriaansen HJ, Hooijkaas H (1987) Immunologic marker analysis of cells in the various hematopoietic differentiation stages and their malignant counterparts. In: Ruiter DJ et al. (eds) Application of monoclonal antibodies in tumor pathology. Nijhoff, Dordrecht, pp 87–116
Kaspers GJL, Pieters R, Van Zantwijk CH et al. (1991) In vitro drug sensitivity of normal peripheral blood lymphocytes and childhood leukaemic cells from bone marrow and peripheral blood. Bn J Canar 64: 469–474
Cline MJ, Rosenbaum E (1968) Prediction of in vivo cytotoxicity of chemotherapeutic agents by their in vitro effect on leukocytes from patients with acute leukemia. Cancer Res 28: 2516–2521
Cantrill HC, Waltman SR, Palmberg PF et al. (1975) In vitro determination of relative corticosteroid potency. J Clin Endocrinol Metab 40: 1073–1077
Berliner DL, Ruhmann AG (1967) Influence of steroids on fibroblasts. I. An in vitro fibroblast assay for corticosteroids. J Invest Dermatol 49: 117–122
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kaspers, G.J.L., Pieters, R., Van Zantwijk, C.H., De Waal, F.C., Van Wering, E.R., Veerman, A.J.P. (1992). Sensitivity of Childhood Acute Lymphoblastic Leukemia Cells to Prednisolone and Dexamethasone Assessed by the MTT Assay. In: Hiddemann, W., Büchner, T., Wörmann, B., Plunkett, W., Keating, M., Andreeff, M. (eds) Acute Leukemias. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 34. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76591-9_52
Download citation
DOI: https://doi.org/10.1007/978-3-642-76591-9_52
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-53949-0
Online ISBN: 978-3-642-76591-9
eBook Packages: Springer Book Archive